St. Jude Children’s Research Hospital scientists report the first successful treatment of a pediatric patient with high-risk refractory neuroblastoma using a targeted therapy guided by clinical genomics…
RNA sequencing identifies the genetic vulnerability BARD1 in a patient with pediatric neuroblastoma
Share.
